Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,228 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07564154RecruitingPhase 1
Testing KT502 injections for active rheumatoid arthritis
This is an early-stage study testing a new injectable treatment called KT502 for people with moderate-to-severe rheumatoid arthritis (RA) that hasn't responded well to standard treatments. The study will check if the medication is safe and how the body responds to it.
Bayswater, VictoriaAges 18–75 - NCT04038840RecruitingPhase 1
Brain PET-MR imaging to study schizophrenia connections
This early (Phase 1) study uses a special brain scan to look at synapses—the contact points between brain cells—in people with schizophrenia-related conditions. It helps researchers understand brain activity and connection patterns, which may guide future tests or treatments.
Palo Alto, CaliforniaAges 18–65 - NCT07568184Recruiting
New Exosome Treatment for Sudden Hearing Loss
This trial tests a new way to deliver anti-inflammatory medicine directly into the ear using tiny particle carriers called exosomes. It's designed for people who lost hearing suddenly without a clear cause and didn't improve with standard steroid pills.
Kafr ash Shaykh, EgyptAges 18–65 - NCT07567287Recruiting
Fat tissue study on how body regulates fat cells
This research study examines fat tissue samples taken during abdominal surgery to understand how the body controls fat cell growth and function. Researchers are comparing samples from people with and without obesity and diabetes to learn more about these processes.
DijonAges 18–80 - NCT07565714Recruiting
AI-Guided Imagery Therapy for Anxiety and Childhood Memories
This research tests a new computer-assisted therapy that helps people with anxiety process difficult childhood memories involving parental criticism. The AI guides you through imagining and reworking these memories to reduce anxiety symptoms.
Poznan, WielkopolskaAges 18–35 - NCT06727721RecruitingPhase 2
Stem cell therapy for hard-to-treat type 2 diabetes
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
ShanghaiAges 18–70 - NCT06738329Recruiting
How seaweed additive carrageenan affects gut bacteria
This study tests whether carrageenan, a seaweed-based food ingredient, changes the balance of bacteria in your gut. It could help us understand how common food additives affect digestion and overall health.
Reading, ReadingAges 18–55 - NCT07557628Recruiting
How Your Brain Responds to High-Fat Meals
This study looks at how a part of your brain called the hypothalamus reacts to eating meals with different amounts of fat. Researchers will use brain imaging (MRI) to watch this response and better understand how diet affects brain inflammation and metabolism.
DijonAges 20 years+ - NCT07557303Recruiting
Understanding Prenatal Screening Decisions During Pregnancy
This study helps pregnant people make informed choices about genetic screening tests by providing clear, timely information. Researchers want to learn the best way to explain screening options so you can decide what's right for you and your family.
San Francisco, CaliforniaAges 18 years+ - NCT07546461Enrolling by invitation
Testing Moon and Mars habitat systems through simulations
This study simulates working and living in lunar habitats, spacecraft during transit, and Mars surface environments. Researchers are testing how equipment, living spaces, and work routines function in these extreme conditions by having participants work through realistic scenarios in controlled settings.
New York, New YorkAges 18–65 - NCT07545122RecruitingPhase 1
Testing CT-202 for Triple Negative Breast, Colorectal, and Bladder Cancers
This early-stage trial tests a new antibody drug called CT-202 in patients whose cancer has come back after standard treatments. The drug is designed to target cancer cells that have a specific protein called Nectin-4, and may help the immune system fight the cancer.
Wahroonga, New South WalesAges 18 years+ - NCT07550010Recruiting
Digital Screening for Cervical Cancer in Cameroon
This study tests a new digital imaging method to help screen women for cervical cancer risk in Cameroon. It may help catch cervical problems earlier using easier-to-read pictures of the cervix.
YaoundéAges 25–50 - NCT07545694Recruiting
Bladder Drug Study for Cancer Patients Undergoing Surgery
This study tests how certain drugs affecting the endocannabinoid system (a natural body signaling pathway) affect bladder muscle function in people with bladder cancer who are preparing for or undergoing surgery. Researchers hope this research will help preserve bladder function during cancer treatment.
RomeAges 18 years+ - NCT05091112Recruiting
Study of nerves during low back surgery
This study looks at tiny nerves in the low back during planned lumbar spine surgery. It may help researchers better understand nerve pathways that contribute to low back pain and nerve-related symptoms.
Aberdeen, ScotlandAges 18 years+ - NCT06126510RecruitingPhase 2
Study of VG161 for advanced bone and soft tissue sarcoma
This trial tests a new virus-based therapy (VG161) injected directly into tumors for people with advanced bone and soft tissue sarcoma that hasn't responded to other treatments. The goal is to see if the virus can shrink tumors and slow the cancer's growth.
BeijingAges 18–75 - NCT06746480RecruitingPhase 2
Study of VG161 for advanced bile duct cancer
This trial tests a new medicine called VG161 for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that has stopped responding to or could not be tolerated after at least one prior treatment. It is given by injection into the tumor, and the study wants to see if it can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18–75 - NCT05300035RecruitingPhase 2
HIV treatment add-on antibodies during early infection
This study tests whether adding two antibody medicines to standard HIV treatment helps people control HIV better after stopping treatment. It focuses on people with recently diagnosed (“primary”) HIV infection, aiming to improve long-term control after ART is interrupted.
BobignyAges 18–70 - NCT07542184Recruiting
Nanochon Chondrograft Knee Cartilage Repair Study
This early-stage study tests a new implant designed to repair damaged knee cartilage. Researchers will evaluate whether this treatment is safe and feasible for people with knee cartilage damage.
Panama City, Provincia de PanamáAges 22–60 - NCT07536061RecruitingPhase 1
Testing SRP-1005 in early-stage Huntington's disease
This first-in-human study tests whether SRP-1005, a new drug, is safe and tolerable in people with early Huntington's disease. The drug is designed to reduce levels of a harmful protein in the brain that causes Huntington's symptoms.
Westmead, New South WalesAges 21–70 - NCT07542808RecruitingPhase 2/Phase 3
Stem cell treatment vs. hyaluronic acid for knee arthritis
This study tests whether an injection of stem cells (special cells that can help repair tissue) works better than a standard hyaluronic acid injection for knee osteoarthritis pain. Both treatments are injected into the knee to reduce pain and improve function.
Abu DhabiAges 18 years+ - NCT06674980Recruiting
Testing placenta-based wound treatment for diabetic and venous leg ulcers
This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.
Metairie, LouisianaAges 18 years+ - NCT07541131Enrolling by invitation
Reducing HIV stigma to improve treatment access for drug users
This study tests whether reducing stigma and discrimination against people who use drugs can help more people access HIV treatment and prevention. You would participate in peer-led group sessions and surveys over 18 months to help researchers understand how stigma affects treatment access in Bishkek.
BishkekAges 18 years+ - NCT06751199Recruiting
Stem cells combined with islet transplant for diabetes
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07527923RecruitingPhase 1
Testing REGN20423 for healthy people and atopic dermatitis
This early-stage trial tests a new experimental medicine called REGN20423 in two groups: healthy volunteers and people with atopic dermatitis (a chronic skin condition causing itching and inflammation). The trial aims to assess whether the medicine is safe and well-tolerated.
Birmingham, AlabamaAges 18–65
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,228 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.